...
首页> 外文期刊>European review for medical and pharmacological sciences. >The association between high-sensitivity C-reactive protein concentration and diabetic nephropathy: a meta-analysis
【24h】

The association between high-sensitivity C-reactive protein concentration and diabetic nephropathy: a meta-analysis

机译:高敏C反应蛋白浓度与糖尿病肾病的关联:一项荟萃分析

获取原文
           

摘要

OBJECTIVE: To explore the association between high-sensitivity C-reactive protein (hs-CRP) concentration and diabetic nephropathy (DN). MATERIALS AND METHODS: We systematically searched Pubmed, Medline and Embase databases up to September, 2014 for the relevant studies. Heterogeneity across studies was evaluated by Cochran’s Q test and I2 statistic. The standard mean difference (SMD) and the corresponding 95% confidence interval (CI) were combined to evaluate the effect size. Sensitivity analysis was also performed by omitting each study to evaluate the stability of the results. In addition, publication bias was tested by Egger’s test. RESULTS: A total of 11 studies containing 1 331 cases and 1 779 controls were included in this study. Significant heterogeneities were observed in our results. The result of meta-analysis showed that the hs-CRP concentrations in DN patients were significantly higher than that in controls of healthy people and diabetes mellitus (DM) patients without nephropathy. In addition, the hs-CRP concentration in macroalbuminuria (D3) group was significantly higher than that in microalbuminuria (D2) group and non-albuminuria group (D1). Sensitivity analysis revealed that the results were stable. As well, no publication bias was observed in our results. CONCLUSIONS: We suggest that hs-CRP concentration can be an indicator of DN in DM patients.
机译:目的:探讨高敏C反应蛋白(hs-CRP)浓度与糖尿病肾病(DN)的关系。材料与方法:我们系统搜索了截至2014年9月的Pubmed,Medline和Embase数据库,以进行相关研究。研究的异质性通过Cochran的Q检验和I2统计进行评估。将标准均值差(SMD)和相应的95%置信区间(CI)组合起来,以评估效果大小。通过省略每项研究来评估结果的稳定性,还进行了敏感性分析。此外,出版物偏倚也通过Egger的测试进行了测试。结果:总共11项研究包括1 331例和1 779名对照。在我们的结果中观察到明显的异质性。荟萃分析结果显示,DN患者的hs-CRP浓度显着高于健康人和无肾病的糖尿病(DM)患者的对照。此外,大型白蛋白尿(D3)组的hs-CRP浓度显着高于微量白蛋白尿(D2)组和非白蛋白尿组(D1)。敏感性分析表明结果是稳定的。同样,在我们的结果中未观察到发表偏见。结论:我们建议hs-CRP浓度可以作为DM患者DN的指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号